| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/13/2004 | WO2004039962A2 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
| 05/13/2004 | WO2004039831A2 Peptide nucleic acid probes for analysis of enterococcus faecium |
| 05/13/2004 | WO2003066859A3 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 05/13/2004 | WO2002030397A9 Liposomes encapsulating anticancer drugs and the use thereof in the treatment of malignant tumors |
| 05/13/2004 | US20040092446 HA-1 epitopes and uses thereof |
| 05/13/2004 | US20040092444 Neuroprotective synergy of erythropoietin and insulin-like growth factor |
| 05/13/2004 | US20040092434 Oligopeptides; antitumor agents, antiinflammatory agents, antiischemic agents, vision defects |
| 05/13/2004 | US20040092015 Coupling; binding aldehyde compound forming hydrazone compound; lipophilic vector |
| 05/13/2004 | US20040091942 Measuring concentration of phospho-tau protein in body/brain fluids for detecting alzheimer's, nervous system and brain disorders |
| 05/13/2004 | US20040091907 GEF-H1b: biomarkers, complexes assays and therapeutic uses thereof |
| 05/13/2004 | US20040091496 Vaccine |
| 05/13/2004 | CA2504443A1 Methods for producing polypeptide-tagged collections and capture systems containing the tagged polypeptides |
| 05/12/2004 | EP1418235A2 Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 05/12/2004 | EP1417228A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417227A2 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 05/12/2004 | EP1417221A2 Mimotope of neisseria meningitidis lipooligosaccharide and vaccines containing the same |
| 05/12/2004 | EP1417219A2 Libraries of conformationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same |
| 05/12/2004 | EP1417055A2 Use of copper chelators to inhibit the inactivation of protein c |
| 05/12/2004 | EP1416951A1 Melanin-concentrating hormone antagonists |
| 05/12/2004 | EP1416934A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 05/12/2004 | EP1194531B1 Cyclic peptidomimetic urokinase receptor antagonists |
| 05/12/2004 | EP1084409B1 Method and device for electrochemical immunoassay of multiple analytes |
| 05/12/2004 | EP1077731A4 Intramolecularly-quenched near infrared fluorescent probes |
| 05/12/2004 | EP1068757B1 A method for controlling connections to a mobile station |
| 05/12/2004 | CN1496369A Modified interferon beta with reduced immunogenicity |
| 05/12/2004 | CN1496368A Immunopotentiators |
| 05/12/2004 | CN1494920A Soft capsule preparation containing cyclosporin |
| 05/12/2004 | CN1494919A Embonate medicine composition containing bombesin-like product |
| 05/12/2004 | CN1494900A Slow releasing composition and its preparing method |
| 05/12/2004 | CN1149288C Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
| 05/12/2004 | CN1149287C Recombinant mersacidin and method for production |
| 05/11/2004 | US6733973 Diagnostic reagents for human cytomegalovirus and methods of use |
| 05/11/2004 | US6733755 Ligand for vascular endothelial growth factor receptor |
| 05/06/2004 | WO2004037854A1 Prion protein-binding peptide sequences |
| 05/06/2004 | WO2003089922A8 Method for detecting ligands and targets in a mixture |
| 05/06/2004 | WO2003016351B1 N - cam related compounds modulating cell groth |
| 05/06/2004 | US20040087768 Process for rapid solution synthesis of peptides |
| 05/06/2004 | US20040087767 FVIIa antagonists |
| 05/06/2004 | US20040087765 Peptides, the production and use thereof for binding immunoglobulins |
| 05/06/2004 | US20040087603 (2s) -2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides |
| 05/06/2004 | US20040087503 Modified ciliary neurotrophic factor (cntf ) with reduced immunogenicity |
| 05/06/2004 | US20040087499 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 05/06/2004 | US20040087496 Use of 3-position cyclosporin derivatives for hair growth |
| 05/06/2004 | US20040087013 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 05/06/2004 | US20040086965 Casein peptide fragments with growth-influencing activity on cell cultures |
| 05/06/2004 | US20040086949 Solid phase synthesis; immunology; vaccines; for generating antibodies; kits |
| 05/06/2004 | US20040086943 Coupling agent containing secordary amide groups |
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086518 Universal vaccine and method for treating cancer employing telomerase reverse transcriptase |
| 05/06/2004 | US20040086512 Multimerization of HIV-1 VIF protein as a therapeutic target |
| 05/06/2004 | EP1415162A2 Novel peptides for the diagnosis of schizophrenia |
| 05/06/2004 | EP1415006A2 Assay for identifying inhibitors of hiv rt dimerization |
| 05/06/2004 | EP1414855A2 Peptide inhibiting platelet derived growth factor (pdgf-bb) and fibroblast growth factor (bfgf) activity |
| 05/06/2004 | EP1414849A2 Immune-modulating peptide |
| 05/06/2004 | EP1414846A2 Molecule |
| 05/06/2004 | EP1414792A1 Fluoro linkers and their use as linkers for enzyme-activated drug conjugates |
| 05/06/2004 | EP1414479A1 Peptide for regulation of tissue plasminogen activator |
| 05/06/2004 | EP1414472A1 Method for preparing fetuin and polypeptide to induce apoptosis |
| 05/06/2004 | EP0871466B1 Linear and cyclic peptides for the treatment or prevention of eczema/dermatitis |
| 05/06/2004 | EP0589004B2 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/05/2004 | CN1494593A Modified ciliary neurotrophic factor (CNTF) with reduced immunogenicity |
| 05/05/2004 | CN1494590A Modified thrombopoietin with reduced immunogenicity |
| 05/05/2004 | CN1148578C Method for immunoassays of specific antibody, reagent, antigen and use thereof |
| 05/05/2004 | CN1148379C Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 05/04/2004 | US6730776 An antimicrobial compound produced by culturing and deacylating in the presence a microbial substance; used for treatment of infectious diseases caused by pathogenic microorganisms such as yeast or fungi |
| 05/04/2004 | US6730304 Viral nuceotide sequences for use in the diagnosis of viral diseases |
| 05/04/2004 | US6730301 Mediating chemotaxis and activation of monocytes; athero-sclerosis; monocyte chemoattractant protein-1 (mcp-1) |
| 05/04/2004 | US6730293 Compositions and methods for treating inflammatory diseases of the skin |
| 05/04/2004 | CA2278057C Tachykinin antagonists |
| 04/29/2004 | WO2004035735A2 A structured peptide scaffold for displaying turn libraries on phage |
| 04/29/2004 | WO2004035614A1 Synthetic or partially purified peptides which can bind to specific subunits of g proteins and uses thereof |
| 04/29/2004 | WO2004035613A2 4-methylhexanoic kahalaide f compound |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035609A2 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions. |
| 04/29/2004 | WO2004035606A2 Bace binding peptides and uses thereof |
| 04/29/2004 | WO2004034977A2 Orally administered peptides synergize statin activity |
| 04/29/2004 | WO2004005920A3 Method for enriching and tracking pathologic modified prions-proteins (prpsc) |
| 04/29/2004 | WO2003057134A3 Specific binding agents of human angiopoietin-2 |
| 04/29/2004 | WO2003053473A3 Ph-sensitive polymeric conjugates of an anthracycline drug |
| 04/29/2004 | WO2003048187A3 Peptides and use thereof in therapeutic agents against hiv infection |
| 04/29/2004 | WO2003004517A3 Peyers's patch and/or m-celle targeting ligands |
| 04/29/2004 | WO2002072612A3 Peptidic modulators of the androgen receptor |
| 04/29/2004 | WO2002038796A9 Methods for determining protease cleavage site motifs |
| 04/29/2004 | WO2002018341A8 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040082760 Process for rapid solution synthesis of peptides |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082757 Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs |
| 04/29/2004 | US20040082517 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 04/29/2004 | US20040082512 Drugs for treatment of inflammation/blood brain barrier degradation |
| 04/29/2004 | US20040082505 Compounds pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia |
| 04/29/2004 | US20040082012 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 04/29/2004 | CA2502411A1 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | CA2502243A1 A structured peptide scaffold for displaying turn libraries on phage |
| 04/29/2004 | CA2501994A1 Use of poly-alpha2,8-sialic acid mimetic peptides to modulate ncam functions |
| 04/29/2004 | CA2501943A1 Orally administered peptides synergize statin activity |
| 04/28/2004 | EP1413583A2 Compounds that inhibit T cell proliferation and methods using the same |
| 04/28/2004 | EP1413297A1 Cyclosporin-containing soft capsule preparations |
| 04/28/2004 | EP1413174A1 Mounting arrangement for auxiliary burner or lance |
| 04/28/2004 | EP1412748A2 Mage-a3 peptides presented by hla class ii molecules |